Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04925648
Title Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction (PICASSO)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors St Vincent's Hospital, Sydney
Indications

prostate cancer

prostate adenocarcinoma

Therapies

Darolutamide + Dasatinib

Dasatinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.